These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8867861)

  • 1. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
    Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
    Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.
    Yang Y; Wilson JM
    J Immunol; 1995 Sep; 155(5):2564-70. PubMed ID: 7650386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
    Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
    J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms.
    Minagawa M; Kawamura H; Liu Z; Govindarajan S; Dennert G
    Liver Int; 2005 Jun; 25(3):622-32. PubMed ID: 15910500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion.
    DeMatteo RP; Markmann JF; Kozarsky KF; Barker CF; Raper SE
    Gene Ther; 1996 Jan; 3(1):4-12. PubMed ID: 8929906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
    Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
    Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination.
    Holst PJ; Ørskov C; Thomsen AR; Christensen JP
    J Immunol; 2010 Apr; 184(8):4431-9. PubMed ID: 20212099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.
    Vassalli G; Agah R; Qiao R; Aguilar C; Dichek DA
    Circ Res; 1999 Oct; 85(9):e25-32. PubMed ID: 10532959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus induced acute hepatitis in non-human primates after liver-directed gene therapy.
    Lu H; Sullivan D; Gerber MA; Dash S
    Chin Med J (Engl); 2002 May; 115(5):726-31. PubMed ID: 12133543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.
    Yang Y; Su Q; Wilson JM
    J Virol; 1996 Oct; 70(10):7209-12. PubMed ID: 8794368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed hematopoietic molecular chimerism results in permanent transgene expression from retrovirally transduced hepatocytes in mice.
    Pichard V; Bellodi-Privato M; Gournay J; Ferry N
    J Gene Med; 2006 Apr; 8(4):425-32. PubMed ID: 16389647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver.
    Yang Y; Greenough K; Wilson JM
    Gene Ther; 1996 May; 3(5):412-20. PubMed ID: 9156802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.
    Yang Y; Ertl HC; Wilson JM
    Immunity; 1994 Aug; 1(5):433-42. PubMed ID: 7533647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy.
    Ghazizadeh S; Harrington R; Taichman L
    Gene Ther; 1999 Jul; 6(7):1267-75. PubMed ID: 10455435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
    Mancini M; Hadchouel M; Tiollais P; Michel ML
    J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
    Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
    Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.